Summary
Library
Citations
Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol. 2007;102:2520-2528.[Abstract]
Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018 Aug;67(8):1380-99.[Abstract][Full Text]
Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007;7:97-105.[Abstract]
1. Holt PR. Intestinal malabsorption in the elderly. Dig Dis. 2007;25:144-150.[Abstract]
2. American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1461-1463.[Abstract]
3. Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol. 2007;102:2520-2528.[Abstract]
4. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018 Aug;67(8):1380-99.[Abstract][Full Text]
5. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920-924.[Abstract]
6. Bossi P, Antonuzzo A, Cherny NI, et al. Diarrhoea in adult cancer patients: ESMO clinical practice guidelines. Ann Oncol. 2018 Oct;29 Suppl 4:iv126-iv142.[Abstract][Full Text]
7. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369.[Abstract][Full Text]
8. National Institute for Health and Care Excellence. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel. October 2013 [internet publication].[Full Text]
9. Kinoshita Y, Ariyoshi R, Fujigaki S, et al. Endoscopic diagnosis of chronic diarrhea. DEN Open. 2022 Apr;2(1):e53.[Abstract][Full Text]
10. Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology. 2006;48:116-132.[Abstract]
11. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem. 2006;52:171-181.[Abstract]
12. Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chin J Dig Dis. 2005;6:122-132.[Abstract]
13. Kalla R, Ventham NT, Satsangi J, et al. Crohn's disease. BMJ. 2014;349:g6670.[Abstract]
14. Kafil TS, Nguyen TM, Patton PH, et al. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2017;11:CD003575.[Abstract][Full Text]
15. Chande N, Al Yatama N, Bhanji T, et al. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev. 2017 Jul 13;7:CD006096.[Abstract][Full Text]
16. Chande N, Driman DK. Microscopic colitis associated with lansoprazole: report of two cases and a review of the literature. Scand J Gastroenterol. 2007;42:530-533.[Abstract]
17. Liszka L, Woszczyk D, Pajak J. Histopathological diagnosis of microscopic colitis. J Gastroenterol Hepatol. 2006;21:792-797.[Abstract]
18. Nyhlin N, Bohr J, Eriksson S, et al. Systematic review: microscopic colitis. Aliment Pharmacol Ther. 2006;23:1525-1534.[Abstract]
19. Tysk C, Bohr J, Olesen M, et al. Microscopic colitis - more common cause of diarrhea than believed. Biopsies are the only way to diagnosis, drug treatment is effective. Lakartidningen. 2005;102:2210-2214.[Abstract]
20. Chang F, Deere H, Vu C. Atypical forms of microscopic colitis: morphological features and review of the literature. Adv Anat Pathol. 2005;12:203-211.[Abstract]
21. Yen EF, Pardi DS. Review article: microscopic colitis - lymphocytic, collagenous and 'mast cell' colitis. Aliment Pharmacol Ther. 2011;34:21-32.[Abstract][Full Text]
22. Münch A, Sanders DS, Molloy-Bland M, et al. Undiagnosed microscopic colitis: a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity. Frontline Gastroenterol. 2020;11(3):228-34.[Abstract][Full Text]
23. Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program. 2007;59:89-101.[Abstract]
24. de Saussure P, Hadengue A. Persistent diarrhea in the returned traveler. Rev Med Suisse. 2006;2:1235-1236, 1238-1239.[Abstract]
25. Diniz-Santos DR, Jambeiro J, Mascarenhas RR, et al. Massive Trichuris trichiura infection as a cause of chronic bloody diarrhea in a child. J Trop Pediatr. 2006;52:66-68.[Abstract]
26. Landzberg BR, Connor BA. Persistent diarrhea in the returning traveler: think beyond persistent infection. Scand J Gastroenterol. 2005;40:112-114.[Abstract]
27. Okhuysen PC. Traveler's diarrhea due to intestinal protozoa. Clin Infect Dis. 2001;33:110-114.[Abstract]
28. Nataro JP, Sears CL. Infectious causes of persistent diarrhea. Pediatr Infect Dis J. 2001;20:195-196.[Abstract]
29. Altuntas B, Gul H, Yarali N, et al. Etiology of chronic diarrhea. Indian J Pediatr. 1999;66:657-661.[Abstract]
30. Feasey NA, Healey P, Gordon MA. The aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther. 2011;34:587-603.[Abstract]
31. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):e45-e80.[Abstract][Full Text]
32. Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med. 1992;116:840-842.[Abstract]
33. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007;7:97-105.[Abstract]
34. Gilkin RJ Jr. The spectrum of irritable bowel syndrome: a clinical review. Clin Ther. 2005;27:1696-1709.[Abstract]
35. Farthing MJ. Functional diarrhea. Curr Gastroenterol Rep. 2005;7:350-357.[Abstract]
36. Naim HY. Molecular and cellular aspects and regulation of intestinal lactase-phlorizin hydrolase. Histol Histopathol. 2001;16:553-561.[Abstract]
37. Sellin JH. The pathophysiology of diarrhea. Clin Transplant. 2001;15(suppl 4):2-10.[Abstract]
38. Ratnaike RN, Jones TE. Mechanisms of drug-induced diarrhoea in the elderly. Drugs Aging. 1998;13:245-253.[Abstract]
39. Shiau YF. Clinical and laboratory approaches to evaluate diarrheal disorders. Crit Rev Clin Lab Sci. 1987;25:43-69.[Abstract]
40. Makins R, Ballinger A. Gastrointestinal side effects of drugs. Expert Opin Drug Saf. 2003;2:421-429.[Abstract]
41. Baker EH, Sandle GI. Complications of laxative abuse. Annu Rev Med. 1996;47:127-134.[Abstract]
42. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445-450.[Abstract]
43. Leffler DA, Kelly CP. Update on the evaluation and diagnosis of celiac disease. Curr Opin Allergy Clin Immunol. 2006;6:191-196.[Abstract]
44. Leffler D, Saha S, Farrell RJ. Celiac disease. Am J Manag Care. 2003;9:825-831.[Abstract]
45. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002 Jan 17;346(3):180-8.[Abstract]
46. Hofmann AF. Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol. 2007;6:15-27.[Abstract]
47. Porter JL, Fordtran JS, Santa Ana CA, et al. Accurate enzymatic measurement of fecal bile acids in patients with malabsorption. J Lab Clin Med. 2003;141:411-418.[Abstract]
48. Lanzini A, Lanzarotto F. Review article: the 'mechanical pumps' and the enterohepatic circulation of bile acids - defects in coeliac disease. Aliment Pharmacol Ther. 2000;14(suppl 2):58-61.[Abstract]
49. DiBaise JK, Paustian FF. Steatorrhea and weight loss in a 72-year-old man: primary biliary cirrhosis? Celiac disease? Bacterial overgrowth? What else? Am J Gastroenterol. 1998;93:2226-2230.[Abstract]
50. Bai J. Malabsorption syndromes. Digestion. 1998;59:530-546.[Abstract]
51. Craddock AL, Love MW, Daniel RW, et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998;274:G157-69.[Full Text]
52. Rossi E, Lentze MJ. Clinical significance of enzymatic deficiencies in the gastrointestinal tract with particular reference to lactase deficiency. Ann Allergy. 1984;53:649-656.[Abstract]
53. Alpers DH, Seetharam B. Pathophysiology of diseases involving intestinal brush-border proteins. N Engl J Med. 1977;296:1047-1050.[Abstract]
54. Sibley E. Carbohydrate intolerance. Curr Opin Gastroenterol. 2004;20:162-167.[Abstract]
55. Riordan SM, Kim R. Bacterial overgrowth as a cause of irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22:669-673.[Abstract]
56. Elphick HL, Elphick DA, Sanders DS. Small bowel bacterial overgrowth. An under recognized cause of malnutrition in older adults. Geriatrics. 2006;61:21-26.[Abstract]
57. Van Citters GW, Lin HC. Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep. 2005;7:317-320.[Abstract]
58. Keller J, Franke A, Storr M, et al. Clinically relevant breath tests in gastroenterological diagnostics - recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases [in German]. Z Gastroenterol. 2005;43:1071-1090.[Abstract]
59. Pimentel M, Saad RJ, Long MD, et al. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020 Feb;115(2):165-78.[Abstract][Full Text]
60. Hammer HF, Fox MR, Keller J, et al. European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus. United European Gastroenterol J. 2022 Feb;10(1):15-40.[Abstract][Full Text]
61. Losurdo G, Leandro G, Ierardi E, et al. Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: a systematic review with meta-analysis. J Neurogastroenterol Motil. 2020 Jan 30;26(1):16-28.[Abstract][Full Text]
62. David-Henriau L, Bui S, Molinari I, et al. Fecal elastase-1: a useful test in pediatric practice [in French]. Arch Pediatr. 2005;12:1221-1225.[Abstract]
63. Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep. 2007;9:116-122.[Abstract]
64. DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol. 2006;22:487-497.[Abstract]
65. Bricker LA, Such F, Loehrke ME, et al. Intractable diarrhea in hyperthyroidism: management with beta-adrenergic blockade. Endocr Pract. 2001;7:28-31.[Abstract]
66. Sharma S, Longo WE, Baniadam B, et al. Colorectal manifestations of endocrine disease. Dis Colon Rectum. 1995;38:318-323.[Abstract]
67. Alam MJ. Chronic refractory diarrhoea: a manifestation of endocrine disorders. Dig Dis. 1994;12:46-61.[Abstract]
68. Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3:43-48.[Abstract]
69. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993;68:691-702.[Abstract]
70. Spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil. 2006;18:1045-1055.[Abstract]
71. Wilson SA, Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol. 2006;22:536-540.[Abstract]
72. Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22:2918-2926.[Abstract]
73. Lee JJ, Furuta GT. Upper gastrointestinal tract eosinophilic disorders: pathobiology and management. Curr Gastroenterol Rep. 2006;8:439-442.[Abstract]
74. Baig MA, Qadir A, Rasheed J. A review of eosinophilic gastroenteritis. J Natl Med Assoc. 2006;98:1616-1619.[Abstract]
75. Sampson HA, Sicherer SH, Birnbaum AH. AGA technical review on the evaluation of food allergy in gastrointestinal disorders. Gastroenterology. 2001;120:1026-1040.[Abstract]
76. Sicherer SH. Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics. 2003;111:1609-1616.[Abstract]
77. Butterfield JH, Murray JA. Eosinophilic gastroenteritis and gluten-sensitive enteropathy in the same patient. J Clin Gastroenterol. 2002;34:552-553.[Abstract]
78. Vanderhoof JA, Young RJ. Allergic disorders of the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2001;4:553-556.[Abstract]
79. Westvik TS, Longo WE. Ischemic colitis. Rozhl Chir. 2005;84:476-481.[Abstract]
80. Sreenarasimhaiah J. Diagnosis and management of ischemic colitis. Curr Gastroenterol Rep. 2005;7:421-426.[Abstract]
81. Green BT, Tendler DA. Ischemic colitis: a clinical review. South Med J. 2005;98:217-222.[Abstract]
82. Misiakos EP, Macheras A, Kapetanakis T, et al. Short bowel syndrome: current medical and surgical trends. J Clin Gastroenterol. 2007;41:5-18.[Abstract]
83. Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci. 2006;331:214-218.[Abstract]
84. Carvajal SH, Mulvihill SJ. Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin North Am. 1994;23:261-279.[Abstract]
85. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am. 1992;72:445-465.[Abstract]
86. Faucheron JL. Toxicity of non-steroidal anti-inflammatory drugs in the large bowel. Eur J Gastroenterol Hepatol. 1999;11:389-392.[Abstract]
87. Zalev AH, Gardiner GW, Warren RE. NSAID injury to the small intestine. Abdom Imaging. 1998;23:40-44.[Abstract]
88. Faucheron JL, Parc R. Non-steroidal anti-inflammatory drug-induced colitis. Int J Colorectal Dis. 1996;11:99-101.[Abstract]
89. Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum. 1995;38:1311-1321.[Abstract]
90. Zhang WY, Li GD, Liu WP, et al. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J (Engl). 2005;118:1542-1548.[Abstract]
91. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464-1486.[Abstract]
92. Florent C, L'Hirondel C, Desmazures C, et al. Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 1981;81:777-780.[Abstract]
93. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol. 2002;76(suppl 2):15-28.[Abstract]
94. Papadopoulou A, Lloyd DR, Williams MD, et al. Gastrointestinal and nutritional sequelae of bone marrow transplantation. Arch Dis Child. 1996;75:208-213.[Abstract]
95. Snover DC. Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol. 1990;14(suppl 1):101-108.[Abstract]
96. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79-S86.[Abstract]
97. Ramakrishna BS, Venkataraman S, Mukhopadhya A. Tropical malabsorption. Postgrad Med J. 2006;82:779-787.[Abstract]
98. Nath SK. Tropical sprue. Curr Gastroenterol Rep. 2005;7:343-349.[Abstract]
99. Westergaard H. Tropical sprue. Curr Treat Options Gastroenterol. 2004;7:7-11.[Abstract]
100. Rodriguez Leal G. Intestinal lymphangiectasia: a forgotten cause of chronic diarrhea. Rev Gastroenterol Mex. 2006;71:55-58.[Abstract]
101. Roy PK, Venzon DJ, Shojamanesh H, et al. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore). 2000 Nov;79(6):379-411.[Abstract]
102. Oberg K, Kvols L, Caplin M, et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol. 2004 Jun;15(6):966-73.[Abstract][Full Text]
103. Eads JR, Reidy-Lagunes D, Soares HP, et al. Differential diagnosis of diarrhea in patients with neuroendocrine tumors. Pancreas. 2020 Oct;49(9):1123-30.[Abstract][Full Text]
104. Selimoglu MA, Esrefoglu M, Gundogdu C. Abetalipoproteinemia: a case report. Turk J Pediatr. 2001;43:243-245.[Abstract]
105. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M. Microsomal triglyceride transfer protein and abetalipoproteinemia. Ann Endocrinol (Paris). 2000;61:125-129.[Abstract]
106. Ogershok PR, Hogan MB, Welch JE, et al. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol. 2006;97:653-656.[Abstract]
107. Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep. 2004;6:377-383.[Abstract]
108. Luzi G, Zullo A, Iebba F, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol. 2003;98:118-121.[Abstract]
109. Bloch-Michel C, Viallard JF, Blanco P, et al. Common variable immunodeficiency: 17 observations in the adult. Rev Med Interne. 2003;24:640-650.[Abstract]
110. el-Salhy M, Nyhlin N, Ando Y, et al. The neuroendocrine system and gastrointestinal complications in patients with familial amyloidosis and polyneuropathy. Scand J Gastroenterol. 1997;32:849-854.[Abstract]
111. Lovat LB, Pepys MB, Hawkins PN. Amyloid and the gut. Dig Dis. 1997;15:155-171.[Abstract]
112. Eganian GA, Arutiunian VM. Gastroenteropathies in patients with periodic disease and amyloidosis [in Russian]. Ter Arkh. 1990;62:79-85.[Abstract]
Key Articles
Other Online Resources
Referenced Articles
Sign in to access our clinical decision support tools